RecruitingNot Applicable

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

Canada300 participantsStarted 2020-02-01

Plain-language summary

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with healthy corneas or suffering from one of these pathologies: Dry eye syndrome; Infectious keratitis and/or conjunctivitis; Mucous membrane pemphigoid; Allergic conjunctivitis. Exclusion Criteria: * Patients younger than 18 years old; * Patients incapable of giving informed consent.

What they're measuring

To obtain the metabolomic and proteomic fingerprint of the studied ocular surface pathologies

Timeframe: 5 years

Trial details

NCT IDNCT04198740

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2034-10

Contact for this trial

Marie-Claude Robert, MD, M.Sc

514-890-8278 marie-claude.robert.2@umontreal.ca

View on ClinicalTrials.gov More Dry Eye Syndrome trials